Middle Eastern Penny Stocks With Market Caps Under US$3B
The Middle Eastern stock markets have been experiencing a positive trend, with Dubai and Abu Dhabi indexes logging their sixth consecutive week of gains. Though the term 'penny stock' might sound like a relic of past trading days, it still highlights smaller or less-established companies that can offer great value. By focusing on those with robust financials and potential for growth, investors can uncover hidden opportunities in these stocks.
Name
Share Price
Market Cap
Financial Health Rating
Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR)
TRY1.79
TRY1.93B
★★★★★☆
Thob Al Aseel (SASE:4012)
SAR4.03
SAR1.65B
★★★★★★
Alarum Technologies (TASE:ALAR)
₪2.849
₪199.52M
★★★★★★
Oil Refineries (TASE:ORL)
₪0.889
₪2.76B
★★★★★☆
Menara Ventures Xl - Limited Partnership (TASE:MNRA)
₪2.719
₪12.49M
★★★★★★
Tgi Infrastructures (TASE:TGI)
₪2.152
₪159.98M
★★★★★★
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.713
AED437.33M
★★★★★★
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.10
AED346.5M
★★★★★★
E7 Group PJSC (ADX:E7)
AED1.01
AED2B
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.37
AED10.08B
★★★★☆☆
Click here to see the full list of 97 stocks from our Middle Eastern Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Dubai Investments PJSC operates in property, investment, manufacturing, contracting, and services sectors both in the UAE and internationally, with a market cap of AED10.08 billion.
Operations: The company's revenue is derived from Property (AED2.14 billion), Manufacturing, Contracting and Services (AED1.39 billion), and Investments (AED272.75 million).
Market Cap: AED10.08B
Dubai Investments PJSC, with a market cap of AED10.08 billion, has shown strong financial performance recently. The company reported first-quarter revenue of AED822.91 million and net income of AED170.89 million, reflecting growth from the previous year. Its price-to-earnings ratio is below the market average, suggesting potential value for investors. Debt management appears effective as its debt to equity ratio has decreased significantly over five years, though interest coverage remains a concern at 2.1x EBIT. Despite robust earnings growth driven by a large one-off gain, forecasts indicate potential earnings decline and dividend sustainability issues due to low free cash flow coverage.
Click here to discover the nuances of Dubai Investments PJSC with our detailed analytical financial health report.
Gain insights into Dubai Investments PJSC's outlook and expected performance with our report on the company's earnings estimates.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret A.S. operates in the manufacturing sector, specializing in vehicle-mounted equipment, with a market cap of TRY1.93 billion.
Operations: Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret A.S. has not reported any specific revenue segments.
Market Cap: TRY1.93B
Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret A.S., with a market cap of TRY1.93 billion, demonstrates strong financial health and growth potential. The company's short-term assets significantly exceed both its short- and long-term liabilities, indicating solid liquidity. Recent earnings results show notable growth, with first-quarter sales rising to TRY527.69 million from TRY509.19 million a year earlier, alongside improved net income of TRY350.24 million compared to TRY231.09 million previously. Despite high volatility in share price and low interest coverage at 1.4x EBIT, the company benefits from reduced debt levels and satisfactory debt management practices over recent years.
Click here and access our complete financial health analysis report to understand the dynamics of Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret.
Gain insights into Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret's past trends and performance with our report on the company's historical track record.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Human Xtensions Ltd. is a medical robotics company that develops, manufactures, markets, and sells modular medical devices for minimally invasive surgical operations in Israel, with a market cap of ₪9.34 million.
Operations: The company generates revenue of ₪0.67 million from its activities in the development, production, marketing, and sale of medical equipment.
Market Cap: ₪9.34M
Human Xtensions Ltd., a medical robotics company, is pre-revenue with annual earnings of ₪0.67 million, indicating its early-stage status. Despite being unprofitable, it has reduced losses by 6.5% annually over the past five years and remains debt-free, reflecting prudent financial management. The company's short-term assets of ₪6.6 million comfortably cover its liabilities of ₪3.7 million, suggesting healthy liquidity despite a cash runway of less than one year if current free cash flow trends persist. While share price volatility remains high and return on equity is negative due to ongoing losses, no significant shareholder dilution occurred recently.
Unlock comprehensive insights into our analysis of Human Xtensions stock in this financial health report.
Examine Human Xtensions' past performance report to understand how it has performed in prior years.
Discover the full array of 97 Middle Eastern Penny Stocks right here.
Contemplating Other Strategies? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DFM:DIC IBSE:KATMR and TASE:HUMX.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
16 hours ago
- Miami Herald
Gucci, YSL owner sends blunt message about tariff threats
I bought my first pair of Saint Laurent (YSL) heels when I was 25. They were all black patent leather in the iconic Tribute style, with crisscross straps and a sky-high platform that made absolutely no sense and every kind of sense at the same time. I can't remember exactly why, but I had some reason to celebrate (or so I told myself), and I couldn't resist the rush of slipping those shoes on in the YSL store at Copley in Boston. They were bold. A little aggressive. And completely, unapologetically French. Related: Popular luxury brand takes a massive leap of faith in risky move That moment wasn't just about fashion - it was about owning something that felt like power. Putting them on was like flipping a switch: confidence, elegance, a little bit of edge. Luxury brands like YSL know exactly what they're selling. Sure, there's craftsmanship and quality, but really, it's culture. A story. An idea that something made in France or Italy is worth paying a premium. So when presidents start throwing around threats of tariffs and urging companies to move production closer to home, that idea gets tested. But Kering (PPRUY) , the company behind Gucci, YSL, and Bottega Veneta, just made it clear: it has no intention of budging. Image source: Sorbis/Shutterstock On the Q1 2025 earnings call, Kering CEO François-Henri Pinault made one thing clear: the company won't be moving its production out of Europe in response to U.S. tariffs. "Most of our brands we are producing in Italy and in France, and this is part of the promise that we bring through our products, through our heritage, to the consumer," he told investors. He went even further, adding, "We are selling part of our culture, being an Italian culture or a French culture. So we have no plan of producing to counter the tariff. It makes no sense." Related: Luxury outerwear brand avoids tariffs as rivals try to exit China His comments came just days after President Donald Trump signaled that sweeping new tariffs on goods from the European Union were imminent, calling the EU's trade actions "an atrocity." Pinault said the company already operates in large global markets (like China) where import duties are standard, and he emphasized that adjusting its entire supply chain would dilute the very value proposition luxury buyers are paying for. Still, Kering isn't ignoring the issue. Pinault acknowledged the company may have to rethink pricing strategy if the tariffs go into effect. Tariffs aren't the only problem on Kering's plate. In its latest results, the group reported a 14% drop in revenue for the first quarter of 2025, totaling €3.9 billion. Gucci continues to struggle. The brand brought in €1.6 billion in Q1 2025, down 24% year-over-year. Sales fell sharply across both its retail and wholesale channels. Meanwhile, YSL posted €679 million in Q1 revenue, down 8%, with some resilience in European and Middle Eastern markets. Kering closed 25 stores globally during the quarter, and although Bottega Veneta (up 4%) and its beauty and eyewear segments saw growth, the group's overall trajectory remains challenged. Pinault addressed the issue, stating, "We are increasing our vigilance to weather the macroeconomic headwinds our industry faces." The company also recently offloaded its stake in The Mall Luxury Outlets and entered a joint venture for three Parisian real estate assets, moves that signal a tighter focus on its core business and brand strategy. Kering's message - heritage over haste - is one not all luxury players may be able to afford. But if it pulls through, it'll be because it stood by elegance, even when tariffs made shortcuts tempting. Related: Versace, Michael Kors, Jimmy Choo stumble hard The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
CNBC
a day ago
- CNBC
Peak private equity? Sector gets defensive about its ability to generate top returns
BERLIN — Private equity's biggest annual gathering is called SuperReturn, but its returns haven't been looking quite so super of late — leading the industry to urge investors to ride out the uncertainty. At this year's conference in Berlin, Germany there was a clear acceptance that a previously forecast 2025 boom in M&A and initial public offering activity has not materialized. And that is putting private equity — which ballooned following the Great Financial Crisis as an alternative funding source to risk-averse banks, now rivaling many of them for size — under pressure. But panels and sideline discussions at the event showed plenty of fighting spirit, with some attendees defending against the narrative that dealmaking is drying up or that the public markets might be a better bet for returns. Many enthused about growth areas ripe for private equity backing, including European defense firms, undervalued mid-caps and Middle Eastern data centers. The event at the Intercontinental Hotel hosted nearly 6,000 attendees this week, with headline keynotes from Carlyle Group Co-chairman David Rubenstein and Blackstone Vice Chair Thomas Nides. Tennis superstar Serena Williams and U2 frontman Bono were also among the speakers. "There is no doubt exits have slowed due to headwinds from geopolitical tension and volatility in public markets. As a result, we have seen companies stay private for longer," said Nalin Patel, lead private capital research analyst at PitchBook. An "exit" refers to when a private equity fund exits its investment in a firm, be it through a sale, IPO or process called a dividend recapitalization. Pitchbook data for the first three months of 2025 showed exit values in Europe dropped 19% quarter-on-quarter, as exit count fell 25.2%. The industry is, meanwhile, holding nearly 30,000 unsold companies worth about $3.6 trillion, according to a March report from Bain. That means limited partners (LPs) — investors in funds — can't realize returns or access cash, while general partners (GPs) — the managers of funds — are spread more thinly across their portfolio companies. U.S. tariffs were repeatedly cited at SuperReturn as having reduced overall market risk appetite, coming just as the industry had been betting on some respite after being rocked by the Covid-19 pandemic, supply chain disruption and higher interest rates. Yann Robard, managing partner at alternative asset manager Dawson Partners, told a packed crowd that private markets are going through a cyclical dip, but that "on average and over the long term, our analysis suggests that private equity outperforms public markets." Assessing data since the start of 2000, Robard said a $1 investment in a Russell 3000 index would have generated a 6.6 times return versus a 19.9 times return in private equity. He added that the sector has better weathered volatility despite its higher leverage — illustrated by a flood of private capital, which has tripled in the last decade from $5 trillion to $17 trillion. Private equity's surge was supported by more than a decade of ultra-low interest rates, with dealmaking hitting a peak in 2021 as low rates met a Covid rebound and fiscal support packages. A core issue hanging over buyout firms now is that many "just paid too much" during that period, said John Romeo, managing partner at management consultancy Oliver Wyman, on the sidelines of the event. "It may have been for good companies, but they just paid too much, so they're not going to make the target returns on those, and that's blocked up the system a little bit. At some point that has to pass," Romeo told CNBC. "I'm still very bullish on private equity." "If I compare how well prepared a private equity firm is in their monthly board meeting with a company, they know the ins and outs of that perfectly, compared to a public market investor who just doesn't have the same level of information or levers to control." Recent years have seen new trends in the private equity world: the rise of continuation vehicles, in which firms essentially dispose of stakes in their companies to new funds they've created; Net Asset Value (NAV) lending, where loans are made against a portfolio's underlying value; and secondaries, in which existing interests or assets are bought from primary private equity investors as a way for LPs to access cash. "The secondary market is hot, it's on fire," said Richard Hope, head of EMEA and global co-head of investments at Hamilton Lane. While it may have arisen as a way to overcome challenges in the industry, Hope said: "Those investing into the secondary market really like it. It's short-duration, it gives you nearer-term liquidity, and it actually gives you an enhanced return. Some investors are looking at in a positive way and want to add it to their portfolio." There has been a push toward getting retail investors involved in the space — traditionally the preserve of large institutional investors — including via an exchange-traded fund launched by State Street and Apollo Global Management in March. Family office representatives were also a notable presence on the ground at SuperReturn. Consolidation has been another consequence of the changing environment, which Rob Lucas, CEO of CVC Capital Partners, expects to continue. He agreed the market sees stronger and weaker cycles, and was currently in the latter, but stressed that making the right investments during periods of volatility generates the strongest returns. "What our LPs are looking for from us is more demanding, in returns, governance, compliance, sustainability, AI. All of these areas are hugely intensive and require depth and strength of platforms," he said during a panel. "Groups coming together is a natural part of that," he said, adding that private equity was still a "super strong asset class" with tailwinds supporting it.o One common refrain at SuperReturn in support of the outlook was the huge amount of "dry powder" — liquid assets — still available for many of the biggest names in the industry to deploy, estimated at over $1 trillion. Despite making the defense case for private equity's future, SuperReturn attendees agreed that huge uncertainty remained regarding the macro environment, not least with the U.S. trade issue far from resolved. A lot is resting on the expectation that fingers are poised on buttons, ready to set deals in motion as soon as some stability returns. Oliver Wyman's Romeo said that private equity has expanded into highly diversified financial institutions but will thrive by focusing on its bread-and-butter roots — finding companies at attractive prices and being laser-focused on improving profitability. "Firms have never had, really, this much money... The entry price that you go in at really matters, but then you've also got to have a real clear plan how you're going to drive that value creation," he added.
Yahoo
a day ago
- Yahoo
Discovering Opportunities: Duran Dogan Basim ve Ambalaj Sanayi And 2 Other Middle Eastern Penny Stocks
As most Gulf markets rise, with Dubai's main index reaching a 17-year high, the Middle East continues to capture investor attention with its robust economic indicators and steady oil prices. Though the term 'penny stocks' might feel like a relic of past market eras, the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials. Name Share Price Market Cap Financial Health Rating Terminal X Online (TASE:TRX) ₪4.37 ₪555.01M ★★★★★★ Menara Ventures Xl - Limited Partnership (TASE:MNRA) ₪2.719 ₪12.49M ★★★★★★ Thob Al Aseel (SASE:4012) SAR4.02 SAR1.6B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.811 ₪197.21M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.14 AED2.26B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY1.79 TRY1.93B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.13 AED361.51M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.41 AED10.25B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.726 AED441.59M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.335 ₪173.59M ★★★★★★ Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Duran Dogan Basim ve Ambalaj Sanayi A.S., along with its subsidiaries, offers packaging products across Turkey and various international markets including Europe, the United States, the Middle East, Africa, and the Asia Pacific; it has a market cap of TRY1.59 billion. Operations: The company's revenue is primarily generated from its Packaging & Containers segment, amounting to TRY1.90 billion. Market Cap: TRY1.58B Duran Dogan Basim ve Ambalaj Sanayi A.S. has shown a reduction in debt levels, with its debt to equity ratio decreasing significantly over the past five years. Despite being unprofitable, the company has managed to reduce its losses annually by 13.4%. Its short-term assets comfortably cover both short and long-term liabilities, indicating a strong liquidity position. However, high net debt to equity remains a concern. Recent earnings reports highlight declining sales and continued net losses, although these losses have narrowed slightly compared to previous periods. The company's dividend is not well covered by earnings, suggesting potential sustainability issues. Dive into the specifics of Duran Dogan Basim ve Ambalaj Sanayi here with our thorough balance sheet health report. Explore historical data to track Duran Dogan Basim ve Ambalaj Sanayi's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Matricelf Ltd is a biotechnology company focused on developing a platform for autologous tissue engineering to address various medical conditions, with a market cap of ₪44.55 million. Operations: Matricelf Ltd does not currently report any revenue segments. Market Cap: ₪44.55M Matricelf Ltd, a pre-revenue biotechnology company with a market cap of ₪44.55 million, recently announced a collaboration with Cellino to advance personalized spinal cord injury treatments. This partnership leverages Cellino's Nebula™ technology and Matricelf's regenerative approach to create scalable therapies. Despite being debt-free and having short-term assets exceeding liabilities, Matricelf faces challenges due to its unprofitability and limited cash runway of less than a year. The management team is experienced, but the board is relatively new. An IND application is planned for next year, aiming to initiate clinical trials for their innovative therapy. Navigate through the intricacies of Matricelf with our comprehensive balance sheet health report here. Gain insights into Matricelf's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ratio Petroleum Energy - Limited Partnership is involved in the exploration, development, and production of oil and gas, with a market cap of ₪62.95 million. Operations: Ratio Petroleum Energy - Limited Partnership has not reported any revenue segments. Market Cap: ₪62.95M Ratio Petroleum Energy - Limited Partnership, with a market cap of ₪62.95 million, is pre-revenue and faces challenges due to its unprofitability and negative return on equity. The company reported a net loss of US$4.18 million for 2024, an improvement from the previous year's larger losses. Despite having no debt and short-term assets exceeding liabilities, its cash runway is limited to less than a year if growth continues at historical rates. The board's average tenure suggests experience; however, the management's experience remains unclear. Share price volatility has decreased but remains high compared to other Israeli stocks. Click here to discover the nuances of Ratio Petroleum Energy - Limited Partnership with our detailed analytical financial health report. Review our historical performance report to gain insights into Ratio Petroleum Energy - Limited Partnership's track record. Embark on your investment journey to our 94 Middle Eastern Penny Stocks selection here. Searching for a Fresh Perspective? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:DURDO TASE:MTLF and TASE:RTPT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
